Parkinson’s Is Not One Disease. Why Are We Still Designing Trials as If It Is?
Real-world evidence (RWE) can help neuroscience sponsors account for disease heterogeneity, identify development risks earlier, and build more precise evidence strategies from Day 1.For decades, Parkinson’s disease has often been approached ...